Short-term alcohol abstinence worsens gut health in alcohol use disorder patients

FHS
June 14, 2024
5:38 am

A study published in PLoS ONE found that short-term abstinence from alcohol in AUD patients exacerbates gut dysbiosis and increases mental distress, contrary to expected improvements.

Aging reorganizes pancreas circadian transcriptome

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 15, Issue 16,

September 6, 2023

Scoop: Infectious disease biotech eyes $25M Series A to advance antibody for chronic lung infection

Infex Therapeutics is planning to raise up to £20 million ($25 million) in a Series A round with an eye to progressing its lead asset

December 6, 2023

Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss | Psychedelic Invest

Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.